Sumitomo Mitsui Trust Holdings Inc. Cuts Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Sumitomo Mitsui Trust Holdings Inc. trimmed its position in Molina Healthcare, Inc. (NYSE:MOH) by 0.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 151,644 shares of the company’s stock after selling 1,323 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned about 0.26% of Molina Healthcare worth $62,300,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. McIlrath & Eck LLC bought a new position in Molina Healthcare during the fourth quarter valued at $34,000. VisionPoint Advisory Group LLC grew its position in Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares in the last quarter. Raleigh Capital Management Inc. increased its stake in Molina Healthcare by 40.4% during the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after acquiring an additional 36 shares during the last quarter. Principal Securities Inc. bought a new stake in Molina Healthcare during the fourth quarter worth approximately $42,000. Finally, Householder Group Estate & Retirement Specialist LLC lifted its stake in shares of Molina Healthcare by 3,933.3% in the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock valued at $43,000 after purchasing an additional 118 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Insider Buying and Selling at Molina Healthcare

In related news, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at $18,504,526.95. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the transaction, the director now directly owns 16,945 shares in the company, valued at $5,816,710.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO James Woys sold 10,000 shares of the stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the sale, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at $18,504,526.95. The disclosure for this sale can be found here. Insiders own 1.11% of the company’s stock.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $293.19 on Friday. Molina Healthcare, Inc. has a fifty-two week low of $288.79 and a fifty-two week high of $423.92. The company has a market capitalization of $17.18 billion, a PE ratio of 15.91, a P/E/G ratio of 0.91 and a beta of 0.58. The company has a 50 day moving average price of $321.87 and a 200-day moving average price of $360.45. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. The business had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the company posted $5.81 EPS. As a group, equities analysts forecast that Molina Healthcare, Inc. will post 23.56 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Bank of America downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. Barclays reduced their target price on shares of Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 25th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. JPMorgan Chase & Co. reduced their price objective on shares of Molina Healthcare from $435.00 to $420.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Finally, Wells Fargo & Company dropped their target price on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a research report on Monday, April 29th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $407.45.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.